Literature DB >> 12374277

The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy.

Gretchen L Eiben1, Markwin P Velders, W Martin Kast.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12374277     DOI： 10.1016/s0065-230x(02)86004-3

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  11 in total

1.  Development of chimeric candidate vaccine against HPV18: a proof of concept.

Authors:  Mohammed Wahiduzzaman; Chandresh Sharma; Bindu Dey; Neerja Bhatla; Neeta Singh
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

2.  Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.

Authors:  Mark L Bagarazzi; Jian Yan; Matthew P Morrow; David B Weiner; Niranjan Y Sardesai; Xuefei Shen; R Lamar Parker; Jessica C Lee; Mary Giffear; Panyupa Pankhong; Amir S Khan; Kate E Broderick; Christine Knott; Feng Lin; Jean D Boyer; Ruxandra Draghia-Akli; C Jo White; J Joseph Kim
Journal:  Sci Transl Med       Date:  2012-10-10       Impact factor: 17.956

3.  The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors.

Authors:  Joeli A Brinkman; Xuemei Xu; W Martin Kast
Journal:  Vaccine       Date:  2007-01-10       Impact factor: 3.641

4.  Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques.

Authors:  Jian Yan; Kristina Harris; Amir S Khan; Ruxandra Draghia-Akli; Duane Sewell; David B Weiner
Journal:  Vaccine       Date:  2008-04-14       Impact factor: 3.641

5.  Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.

Authors:  Shehnaz K Hussain; Margaret M Madeleine; Lisa G Johnson; Qin Du; Mari Malkki; Hui-Wen Wilkerson; Federico M Farin; Joseph J Carter; Denise A Galloway; Janet R Daling; Effie W Petersdorf; Stephen M Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

6.  Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer.

Authors:  Fatimah Jaafar; Elda Righi; Victoria Lindstrom; Christine Linton; Mahrokh Nohadani; Susan Van Noorden; Tyler Lloyd; Joshua Poznansky; Gordon Stamp; Roberto Dina; Dulcie V Coleman; Mark C Poznansky
Journal:  Am J Pathol       Date:  2009-10       Impact factor: 4.307

7.  Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen.

Authors:  Jian Yan; Dawn K Reichenbach; Natasha Corbitt; David A Hokey; Mathura P Ramanathan; Kibwei A McKinney; David B Weiner; Duane Sewell
Journal:  Vaccine       Date:  2008-11-18       Impact factor: 3.641

8.  Sequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strains.

Authors:  Krishna P Singh; Neeraj Verma; Bashir A Akhoon; Vishal Bhatt; Shishir K Gupta; Shailendra K Gupta; Suchi Smita
Journal:  3 Biotech       Date:  2016-01-27       Impact factor: 2.406

9.  Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer.

Authors:  B S Nedergaard; M Ladekarl; H F Thomsen; J R Nyengaard; K Nielsen
Journal:  Br J Cancer       Date:  2007-10-16       Impact factor: 7.640

Review 10.  Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response.

Authors:  Alfredo Amador-Molina; José Fernando Hernández-Valencia; Edmundo Lamoyi; Adriana Contreras-Paredes; Marcela Lizano
Journal:  Viruses       Date:  2013-10-28       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.